Home
Home
Doneer nu!

Gefinancieerd onderzoek

Ook in 2017 heeft de Trombosestichting een financieringsronde georganiseerd. Na het oordeel van de Wetenschappelijke Adviesraad gehoord te hebben, heeft de Trombosestichting besloten de volgende projecten te financieren:

  • Prof. dr. Harry Büller (AMC) -
    Tumor-educated platelets to screen for occult cancer in patients with unprovoked venous thromboembolism: PLATO-VTE study

  • Ruben Bierings, PhD en Coert Margadant, PhD (Sanquin) -
    The only way is up: polarized secretion and tethering of VWF by adhesion molecules

  • Coen Maas, PhD (UMC Utrecht) -
    Platelet Polyphosphate: Nature's Nanoparticles 

Hiernaast financiert de Trombosestichting nog twaalf andere onderzoeksprojecten:

  • Dr. Gerry Nicolaes (Maastricht UMC)
    Targeting of Extracellular Histinones by Rationally Engineered Proteases to Prevent and Treat Immunothrombotic Disease

  • Prof. dr. Suzanne Cannegieter (LUMC)
    Leiden Thrombosis Risk Prediction after plaster cast immobilization and after knee arthroscopy (L-TRiP (cast) and L-TRip (scopy) studies

  • Dr. Brenda Luken en dr. D. Wouters (Sanquin)
    The H is for Hemostasis: how factor H complements to ADAMTS13 in regulating von Willebrand factor-mediated thrombus formation under flow

  • Prof. dr. Sascha Zeerleder (AMC)
    It takes two to tango: Neutrophil-extracellular traps and complement activation in the pathogenesis of thrombosis in autoimmune hemolytic anemia
  • Prof.dr. Ton Lisman (UMC Groningen)
    Regulating autophagy: a novel antithrombotic strategy

  • Dr. Kees van 't Veer (AMC) en dr. Mettine Bos (LUMC)
    Uncovering the role of FXa-dependent FV activation in thrombosis or bleeding

  • Dr. Ruben Bierings en prof.dr. Jan Voorberg (Sanquin)
    Caught in a trap: Unravelling von Willebrand factor extracellular traps

  • Dr. Bart van Vlijmen (LUMC)
    The role of the Solute Carrier Transporter 44A2 (SLC44A2) Gene in the Pathophysiology of Venous Thromboembolism

  • Dr. E. Castoldi (Maastricht UMC)
    Characterisation of factor V-short: a new player in the TFPI system?

  • Dr. L.J. Schurgers (Maastricht UMC)
    Effects of vitamin-antagonists, vitamin K and new oral anticoagulants on atherogenesis

  • Prof.dr. M.V. Huisman (LUMC)
    Safety of excluding recurrent deep vein thrombosis of the leg with magnetic resonance direct thrombus imaging – The Theia Study

  • Dr. M.P.M. de Maat en dr. H.M.M. van Beusekom (Erasmus MC)
    Functional three-dimensional architecture of the coronary thrombus in relation to phenotype: in vivo and in vitro thrombus fate

In het wetenschappelijk jaarverslag leest u de voortgangsverslagen van de lopende onderzoeksprojecten.